https://www.selleckchem.com/pr....oducts/lenalidomide-
https://www.selleckchem.com/pr....oducts/lenalidomide-
Shielding aftereffect of dexmedetomidine upon neuronal hypoxic injuries by way of inhibition associated with miR-134. 4±2.1% to 49.6±2.0%, p0.05) and asymptomatic (50.9±1.8% to 50.4±1.9%, p0.05) eyes of CSR patients. No difference for any mean VD of the control group was seen between the baseline and after BHM. Outer retinal flow areas increased significantly after BHM compared with the baseline in both eyes of CSR patients. These results suggest that
Curtir
Comentario
Compartilhar
